推进免疫功能受损患者感染事件标准化报告的共识立场声明
该共识针对免疫功能受损患者感染事件报告不统一的问题,提出核心报告数据集(类别、部位、严重程度、病原体、终点)作为最低报告标准,并建议根据研究类型补充信息,以改善诊断、治疗和预防并促进未来研究。
要点
- 核心报告数据集包括感染类别、部位、严重程度、病原体和终点五项最低标准。
- 不同研究类型需在核心数据集基础上补充额外信息。
- 标准化报告感染事件及归因并发症可改善诊疗预防并促进研究。
核心结论
- 标准化报告免疫功能受损患者的感染事件及归因并发症将改善诊断、治疗和预防方法,并促进该患者群体的未来研究。
研究设计与样本
- Lancet Infect Dis 发布的共识立场声明,旨在推进免疫功能受损患者感染事件的标准化报告。
主要发现
- 随机试验中感染事件报告缺乏足够细节,观察性和登记研究中感染分类与定义不一致限制了可比性和未来数据合并。
关键数值与推荐
- 核心报告数据集由类别、部位、严重程度、病原体和终点组成,作为跨研究类型报告免疫功能受损患者感染事件的最低标准。
- 建议根据研究类型补充额外信息。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Patients can be immunocompromised from a diverse range of disease and treatment factors, including malignancies, autoimmune disorders and their treatments, and organ and stem-cell transplantation. Infections are a leading cause of morbidity and mortality in immunocompromised patients, and the disease treatment landscape is continually evolving. Despite being a critical but preventable and curable adverse event, the reporting of infection events in randomised trials lacks sufficient detail while inconsistency of categorisation and definition of infections in observational and registry studies limits comparability and future pooling of data. A core reporting dataset consisting of category, site, severity, organism, and endpoints was developed as a minimum standard for reporting of infection events in immunocompromised patients across study types. Further additional information is recommended depending on study type. The standardised reporting of infectious events and attributable complications in immunocompromised patients will improve diagnostic, treatment, and prevention approaches and facilitate future research in this patient group.
引用
- Teh BW, Mikulska M, Averbuch D, et al. Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients. Lancet Infect Dis. 2023. PMID: 37683684. doi:10.1016/S1473-3099(23)00377-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。